This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Investigations

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • routine haematologic and biochemical studies

  • abdominal radiograph - calcifications in a younger patient may be due to a benign cystic teratoma, the most common neoplasm in patients under 25 years

  • barium enema - to rule out ovarian metastases from a primary colonic cancer in older patients

  • breast mammography - in patients with suspicious breast lumps to eliminate breast metastases

  • pelvic ultrasonography, especially transvaginally - more effective than CT as provides information which is predictive of cancer. Unilocular cystic masses are generally, benign cysts; predominantly solid or multilocular masses are likely to be neoplastic

  • serum tumour markers - CA-125 is elevated in 80% of patients with advanced ovarian cancer. But this marker may also be elevated other cancers and non-malignant conditions (see menu).
  • endometrial biopsy - if abnormal vaginal bleeding - to exclude concurrent primary endometrial and ovarian tumours

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.